|
|
In a research study funded by speciality chemistry company Cognis and using Cognis’ Tonalin branded CLA (a mixture of isomers: cis-9, trans-11 – 36.4% – and trans-10, cis-12 37%) 28 overweight mild asthmatics aged between 19 and 40 were recruited to participate in a prospective, randomized, double-blind, placebo-controlled study. Subjects were randomly assigned to receive either 4.5 grams per day of CLA or placebo for 12 weeks. Clinical & Experimental Allergy
July 2010, Volume 40, Pages 1071-1078
|